Development and comparative evaluation of immunoblot assays for detecting autoantibodies to Scl 70 and Jo 1 antigens in serum.

We developed rapid 24-h immunoblot assays for detecting autoantibodies to Scl 70 and Jo 1 antigens in serum. In comparative studies, we evaluated the analytical sensitivity of the immunoblot assays and commercial immunodiffusion assays for anti-Scl 70 and anti-Jo 1 autoantibodies with the use of positive control sera, and compared the frequencies of positive and negative results in a group of 116 sera, including specimens from 34 healthy controls and 82 patients with various connective-tissue diseases. The immunoblot assays were greater than 100-fold more sensitive than immunodiffusion for detecting both autoantibodies. Despite greater analytical sensitivity, there were no false-positive results by the immunoblot assay for anti-Scl 70 or anti-Jo 1 autoantibodies in sera from either the controls or the patients. The diagnostic sensitivity of the immunoblot assay for anti-Scl 70 autoantibodies in patients with scleroderma was greater than that of the immunodiffusion assay, 70% vs 20%, and was equivalent in patients with polymyositis, 43%. We conclude that rapid immunoblot assays for anti-Scl 70 and anti-Jo 1 autoantibodies are superior to immunodiffusion assays for clinical use and are suitable for routine use in the clinical laboratory.

[1]  Miguel Ángel Martínez,et al.  Characterization of the antigen reactive with anti-Scl-70 antibodies and its application in an enzyme-linked immunosorbent assay. , 1988, Arthritis and rheumatism.

[2]  M. Reichlin,et al.  Measurement of antibody to Jo-1 by ELISA and comparison to enzyme inhibitory activity. , 1987, Journal of immunology.

[3]  F. Miller,et al.  An enzyme-linked immunosorbent assay for the detection and quantitation of anti-Jo-1 antibody in human serum. , 1987, Journal of immunological methods.

[4]  F. Miller,et al.  An efficient method for enrichment of histidyl-tRNA synthetase (Jo-1 antigen) from HeLa cells. , 1987, Journal of immunological methods.

[5]  D. Isenberg,et al.  Autoantibodies against a specific nuclear RNP protein in sera of patients with autoimmune rheumatic diseases associated with myositis. , 1987, Journal of immunology.

[6]  E. Beutner,et al.  Scl 70 antibody—a specific marker of systemic sclerosis , 1986, The British journal of dermatology.

[7]  C. Geisler,et al.  An enzyme-linked immunosorbent assay for autoantibodies against the nuclear protein Scl-70. , 1985, Journal of immunological methods.

[8]  Y. Moroi,et al.  Antinuclear antibodies in the relatives of patients with systemic sclerosis , 1985, The British journal of dermatology.

[9]  F. Arnett,et al.  Antibody to Jo-1 in polymyositis/dermatomyositis: association with interstitial pulmonary disease. , 1984, The Journal of rheumatology.

[10]  M. Mathews,et al.  Anti-Jo-1 antibody: a marker for myositis with interstitial lung disease. , 1984, British medical journal.

[11]  T. Mimori,et al.  The precipitating antibody to an acidic nuclear protein antigen, the Jo-1, in connective tissue diseases. A marker for a subset of polymyositis with interstitial pulmonary fibrosis. , 1983, Arthritis and rheumatism.

[12]  G. Hughes,et al.  Serological markers in progressive systemic sclerosis: clinical correlations. , 1983, Annals of the rheumatic diseases.

[13]  J F Fries,et al.  The 1982 revised criteria for the classification of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.

[14]  M. Ellison,et al.  Purification and properties of type 1 topoisomerase from chicken erythrocytes: mechanism of eukaryotic topoisomerase action. , 1982, Biochemistry.

[15]  E. Tan,et al.  Autoantibodies to nuclear antigens (ANA): their immunobiology and medicine. , 1982, Advances in immunology.

[16]  F. Arnett,et al.  The Jo-1 antibody system in myositis: relationships to clinical features and HLA. , 1981, The Journal of rheumatology.

[17]  M. Reichlin,et al.  Heterogeneity of precipitating antibodies in polymyositis and dermatomyositis. Characterization of the Jo-1 antibody system. , 1980, Arthritis and rheumatism.

[18]  E. Tan,et al.  Identification of a nuclear protein (Scl-70) as a unique target of human antinuclear antibodies in scleroderma. , 1979, The Journal of biological chemistry.